6.
Sparber-Sauer M, Stegmaier S, Vokuhl C, Seitz G, von Kalle T, Scheer M
. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS). Pediatr Blood Cancer. 2019; 66(6):e27652.
DOI: 10.1002/pbc.27652.
View
7.
Rhee D, Rodeberg D, Baertschiger R, Aldrink J, Lautz T, Grant C
. Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee. J Pediatr Surg. 2020; 55(10):1987-1995.
DOI: 10.1016/j.jpedsurg.2020.06.015.
View
8.
Kitagawa N, Arata J, Ohtsuki Y, Hayashi K, Oomori Y, Tomoda T
. Congenital alveolar rhabdomyosarcoma presenting as a blueberry muffin baby. J Dermatol. 1989; 16(5):409-11.
DOI: 10.1111/j.1346-8138.1989.tb01291.x.
View
9.
Rekhi B, Qureshi S, Narula G, Gujral S, Kurkure P
. Rapidly progressive congenital rhabdomyosarcoma presenting with multiple cutaneous lesions: an uncommon diagnosis and a therapeutic challenge. Pathol Res Pract. 2014; 210(5):328-33.
DOI: 10.1016/j.prp.2014.02.001.
View
10.
Shern J, Yohe M, Khan J
. Pediatric Rhabdomyosarcoma. Crit Rev Oncog. 2015; 20(3-4):227-43.
PMC: 5486973.
DOI: 10.1615/critrevoncog.2015013800.
View
11.
Russo I, Di Paolo V, Gurnari C, Mastronuzzi A, Del Bufalo F, Di Paolo P
. Congenital Rhabdomyosarcoma: a different clinical presentation in two cases. BMC Pediatr. 2018; 18(1):166.
PMC: 5953406.
DOI: 10.1186/s12887-018-1128-5.
View
12.
Gallego S, Chi Y, De Salvo G, Li M, Merks J, Rodeberg D
. Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups. Pediatr Blood Cancer. 2020; 68(3):e28832.
PMC: 8414760.
DOI: 10.1002/pbc.28832.
View
13.
Shern J, Selfe J, Izquierdo E, Patidar R, Chou H, Song Y
. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. J Clin Oncol. 2021; 39(26):2859-2871.
PMC: 8425837.
DOI: 10.1200/JCO.20.03060.
View
14.
Hibbitts E, Chi Y, Hawkins D, Barr F, Bradley J, Dasgupta R
. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group. Cancer Med. 2019; 8(14):6437-6448.
PMC: 6797586.
DOI: 10.1002/cam4.2504.
View
15.
Godambe S, Rawal J
. Blueberry muffin rash as a presentation of alveolar cell rhabdomyosarcoma in a neonate. Acta Paediatr. 2000; 89(1):115-7.
DOI: 10.1080/080352500750029185.
View
16.
Ferrari A, Orbach D, Sultan I, Casanova M, Bisogno G
. Neonatal soft tissue sarcomas. Semin Fetal Neonatal Med. 2012; 17(4):231-238.
DOI: 10.1016/j.siny.2012.05.003.
View
17.
Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe M, van Unnik A
. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. J Clin Oncol. 2005; 23(19):4363-71.
DOI: 10.1200/JCO.2005.12.009.
View